Indeed, FST is consistently found to be secreted by solid tumors, including melanomas, ovarian adenocarcinomas, and lung adenocarcinomas, and its expression exhibits a notable upregulation when compared to normal tissue samples [66,67,68]. The gene discussed is FST; the disease is melanoma.